Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LOL, “new” MYDX CEO Daniel Yazbeck?
Uhhhh, might want to do a little more DD on MYDX.
New MYDX 52-week low of .0002
Nah, the CEO still has at least two billion restricted shares and a ton unrestricted through his privately-held “consulting” company.
I do believe in PLNHF, but I think they’re going to need more bought-deal financing to build out Santa Ana.
The consumption room moratorium was a blow to how high this thing will go in the next couple of years.
Vegas Casinos will likely grease the NV politicians to allow them to build cannabis consumption rooms, so that makes the hill a little steeper for Planet. Still think this company is a nice one to get back in to again.....in due time.
I think you’ll get it. I bought PLNHF awhile ago and took my profits before it fell again. I’m waiting for a similar re-entry point as yours.
The plateauing monthly numbers then the two-year consumption lounge moratorium put in by the NV gubmint told me headwinds are coming.
The news of two Canadian cannabis growers issuing some really bad news is killing the sector today, including Planet.
This additional weight on the sector is going to test Planet’s $1.65 support level. It held today when the PLNHF SP dipped to $1.63 and popped back up to $1.66.
If the $1.65 support breaks, next support for PLNHF is of moderate level around $1.31. If that breaks, it’ll be a fast-track to 90 cents.
A lot of companies will be reporting in the next four weeks. They are completely out of Planet’s, well, orbit....but will weigh down the entire sector, and the PLNHF SP will probably be dragged down as well.
Technical, fundamental, common sensical....it doesn't matter the angle looked at, GRNH has a rich history of selling the world and not coming through with anything.
Remember igot420? Shareholders got screwed.
Look at the fins and PRs from two, three or four years ago.....what has actually panned out?
Mighty interesting to wonder how many of those 1-50 ROES in the complaint against MYDX will involve those who lied about imminent MYDX product releases with Slimpen and about the pen's release in general?
Loaded questions are inherently fallacious
What about all the false statements against MYDX regarding ECOSmartPen not being a product?
What is ECOSmartPen.com
What is MYDX360 product platform
What's saving MYDX from its own business death?
OrganaDX has been “coming soon” since 2015.
This passage did catch my eye...
The CannaDx business profits, however, are not yet sufficient to support the additional expenses required to operate and maintain a fully reporting and audited publicly traded company.
If it ever existed.
It’s truly breathtaking to see how much time, attention and money was spent on hyping up the alleged pen.
The supposed medical designation application, the supposed Israeli clinical trials, the Erai Beckmann dog and pony show.....all that money MYDX spent for an initiative that never saw the light of day, and has been discarded like an old pizza box.
All gone.
By the MYDX Shareholders Letter, it appears the company is abandoning what has been hyped for the past two years in the alleged vape pen.
How much money did MYDX spend on the pen? And for nothing.
Because we’ve heard it all before. It’s just another pivot in a company that has been mostly talk and less about actual delivering.
OrganaDX has been “coming soon” since 2015.
This passage did catch my eye...
The CannaDx business profits, however, are not yet sufficient to support the additional expenses required to operate and maintain a fully reporting and audited publicly traded company.
How much should those who lied about MYDX products being released with Slimpen have to pay?
Bummer how all the rumors about the “forced this party selling” were untrue. Just all dilution. So much for Beckmann’s “it’s gonna be a great summer.”
At least we know where the "forced seller" laugh track originates....
On April 25, 2019, the Company issued 10,000,000 shares of common stock for the conversion of $15,000 of a convertible note.
On April 26, 2019, the Company issued 10,000,000 shares of common stock for the conversion of $15,000 of a convertible note.
On April 29, 2019, the Company issued 10,000,000 shares of common stock for the conversion of $15,000 of a convertible note.
On April 29, 2019, the Company issued 11,398,855 shares of common stock for the conversion of $16,726 of a convertible note.
On April 30, 2019, the Company issued 8,035,900 shares of common stock for the conversion of $10,447 of a convertible note.
On May 3, 2019, the Company issued 11,538,462 shares of common stock for the conversion of $15,000 of a convertible note.
On May 6, 2019, the Company issued 18,181,818 shares of common stock for the conversion of $20,000 of a convertible note.
On May 7, 2019, the Company issued 10,059,827 shares of common stock for the conversion of $10,462 of a convertible note.
On May 8, 2019, the Company issued 14,545,455 shares of common stock for the conversion of $16,000 of a convertible note.
On May 9, 2019, the Company issued 17,818,182 shares of common stock for the conversion of $19,600 of a convertible note.
On May 10, 2019, the Company issued 12,389,219 shares of common stock for the conversion of $10,469 of a convertible note.
On June 11, 2019, the Company issued 22,455,787 shares of common stock for the conversion of $14,821 of a convertible note.
On June 12, 2019, the Company issued 13,515,667 shares of common stock for the conversion of $10,542 of a convertible note.
On June 24, 2019, the Company issued 18,088,883 shares of common stock for the conversion of $10,853 of a convertible note.
On June 27, 2019, the Company issued 26,597,266 shares of common stock for the conversion of $15,958 of a convertible note.
On July 2, 2019, the Company issued 20,148,148 shares of common stock for the conversion of $10,880 of a convertible note.
On July 9, 2019, the Company issued 25,960,310 shares of common stock for the conversion of $10,903 of a convertible note.
On July 10, 2019, the Company issued 46,741,166 shares of common stock for the conversion of $19,631 of a convertible note.
On July 18, 2019, the Company issued 36,444,433 shares of common stock for the conversion of $10,933 of a convertible note.
On July 24, 2019, the Company issued 45,638,875 shares of common stock for the conversion of $10,953 of a convertible note.
On July 26, 2019, the Company issued 51,014,833 shares of common stock for the conversion of $12,244 of a convertible note.
On July 31, 2019, the Company issued 45,736,125 shares of common stock for the conversion of $10,977 of a convertible note.
On August 7, 2019, the Company issued 45,833,333 shares of common stock for the conversion of $11,000 of a convertible note.
On August 12, 2019, the Company issued 61,203,722 shares of common stock for the conversion of $11,017 of a convertible note.
No MYDX product please happened on Friday, and nothing came out Monday. What happened? Where is it?
WITH SEC FILING I EXPECT GOOD.NEWS.OR PRODUCT.RELEASE.LATER.TODAY.OR.ON.MONDAY.
Conditions Are Well Set Up For MYDX Positive.PR.On.Monday
The tooling cost listed in last year's MYDX fins was touted as concrete evidence of a Pen. But like you said, no manufacturer and no Pen.
Can't wait for Defendant Yazbeck testify under oath.
Right...will be fun to see Defendant Yazbeck testify under oath.
Right, “matter” and “case” are mutually exclusive terms.
The settlement terms MYDX mentioned last year were acknowledged in April as having been settled.
But it seems this is the only thing going on for MYDX, so I get why some don’t want to let this go, even though it’s been in the court’s rear view mirror for over a year now.
Great....good luck! Say, if this case
Isn’t dismissed, what’s the case number?
What partners? Neither of the past couple of MYDX financials say there are any partners.
It doesn’t say that.
Yet ZERO mentions in the last two MYDX financials of any such thing. ZERO.
It’ unclear if the tooling costs were for the new analyzer or the pen.
Please. The tooling costs started how many years ago? We’re coming up on the two and a half YEARS since MYDX first announced the alleged pen.
The company can do all the tricks with the books they want, the bottom line is that MYDX hasn’t released the Pen, nor has it released the three additional sensors Yazbeck has been saying are “coming soon” since 2015.
TSX has nothing to do with MYDX, its all about US legalisation in the scenario described.
There’s already a well-known Canadian cannabis company that has a deal with a US MSO, but they cannot pull the trigger on it until US legalisation.
Little to no effect to MYDX. Nobody is interested in a company that recorded ZERO product revenue in Q2 2019 ($1,539 in Q1), and is being sued by its former Chief Medical Officer.
And it only cost MYDX $128,342 in operating expenses to achieve ZERO dollars in Q2 2019 sales.
And nothing in tooling costs. Soooo.....where’s that MYDX Pen now?
MYDX pissing off shareholders by having ZERO product revenue in Q2 2019.
Wasn't the MYDX Pen supposed to come out August 19th or 20th?
Which also says how long the company been saying the pen is "coming soon"....coming up on two and a half years now.
Wonder if the company has refunded the monies of people who bought AeroDX, AquaDX and OrganaDX, which have been "coming soon" since 2015.
10Q Lowlights:
The MYDX OS went from 4,648,547,212 on this last Monday's TA report to 4,814,093,774 yesterday, Thursday's 10-Q, October 3rd? Did the MYDX OS really gain 3.6% in three days?! DAMN!
Q2 2019 Revenue: $867.00. There are no zeroes missing, that's $867. MYDX raked in ZERO product revenue in Q2 2019 and hauled in $867 in licensing revenue. Does that even pay the utility bill for Q2 2019?
Wonder who these "vendors" were?.....
On April 17, 2019, the Company issued 50,000,000 shares of its restricted common stock to settle outstanding vendor liabilities of $64,000. In connection with this transaction the Company also recorded a loss on settlement of vendor liabilities of $56,000. The fair value of the common stock based on the trading price of the stock on April 17, 2019 was $120,000.
On May 13, 2019, the Company issued 100,000,000 shares of its restricted common stock to settle outstanding vendor liabilities of $96,788. In connection with this transaction the Company also recorded a loss on settlement of vendor liabilities of $53,212. The fair value of the common stock based on the trading price of the stock on May 13, 2019 was $150,000.
During the six months ended June 30, 2019 the lenders converted $207,200 of the outstanding principal and $8,678 of the outstanding interest into 214,625,321 shares of the Company’s common stock.
Litigation
In the normal course of business, the Company may be subject to other legal proceedings, lawsuits and other claims. Although the ultimate aggregate amount of probable monetary liability or financial impact with respect to these matters is subject to many uncertainties and is therefore not predictable with assurance, the Company’s management believes that any monetary liability or financial impact to the Company from these other matters, individually and in the aggregate, would not be material to the Company’s financial condition, results of operations or cash flows.
However, there can be no assurance with respect to such result, and monetary liability or financial impact to the Company from these other matters could differ materially from those projected.
MyDx plans to develop additional smart hardware that gather user data, such as the Eco Smart Pen. MyDx plans to release the Eco Smart Pen in the first quarter of 2019.
Other than as reported in our Current Reports on Form 8-K, or prior periodic reports, we have not sold any of our equity securities during the period covered by this Quarterly Report, except as set forth below:
On April 25, 2019, the Company issued 10,000,000 shares of common stock for the conversion of $15,000 of a convertible note.
On April 26, 2019, the Company issued 10,000,000 shares of common stock for the conversion of $15,000 of a convertible note.
On April 29, 2019, the Company issued 10,000,000 shares of common stock for the conversion of $15,000 of a convertible note.
On April 29, 2019, the Company issued 11,398,855 shares of common stock for the conversion of $16,726 of a convertible note.
On April 30, 2019, the Company issued 8,035,900 shares of common stock for the conversion of $10,447 of a convertible note.
On May 3, 2019, the Company issued 11,538,462 shares of common stock for the conversion of $15,000 of a convertible note.
On May 6, 2019, the Company issued 18,181,818 shares of common stock for the conversion of $20,000 of a convertible note.
On May 7, 2019, the Company issued 10,059,827 shares of common stock for the conversion of $10,462 of a convertible note.
On May 8, 2019, the Company issued 14,545,455 shares of common stock for the conversion of $16,000 of a convertible note.
On May 9, 2019, the Company issued 17,818,182 shares of common stock for the conversion of $19,600 of a convertible note.
On May 10, 2019, the Company issued 12,389,219 shares of common stock for the conversion of $10,469 of a convertible note.
On June 11, 2019, the Company issued 22,455,787 shares of common stock for the conversion of $14,821 of a convertible note.
On June 12, 2019, the Company issued 13,515,667 shares of common stock for the conversion of $10,542 of a convertible note.
On June 24, 2019, the Company issued 18,088,883 shares of common stock for the conversion of $10,853 of a convertible note.
On June 27, 2019, the Company issued 26,597,266 shares of common stock for the conversion of $15,958 of a convertible note.
On July 2, 2019, the Company issued 20,148,148 shares of common stock for the conversion of $10,880 of a convertible note.
On July 9, 2019, the Company issued 25,960,310 shares of common stock for the conversion of $10,903 of a convertible note.
On July 10, 2019, the Company issued 46,741,166 shares of common stock for the conversion of $19,631 of a convertible note.
On July 18, 2019, the Company issued 36,444,433 shares of common stock for the conversion of $10,933 of a convertible note.
On July 24, 2019, the Company issued 45,638,875 shares of common stock for the conversion of $10,953 of a convertible note.
On July 26, 2019, the Company issued 51,014,833 shares of common stock for the conversion of $12,244 of a convertible note.
On July 31, 2019, the Company issued 45,736,125 shares of common stock for the conversion of $10,977 of a convertible note.
On August 7, 2019, the Company issued 45,833,333 shares of common stock for the conversion of $11,000 of a convertible note.
On August 12, 2019, the Company issued 61,203,722 shares of common stock for the conversion of $11,017 of a convertible note.
The securities described above were issued pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended.
The Company has not repurchased shares of its common stock.
Wasn't that warrant extended to November 10, 2022?
Are you short?
0 debt in its books
30M in current assets
11M in current liabilities.
Cash Flow positive
Phase2 paid for
Capex for Cali opening 6M
Yazbeck still has $1M in restricted shares to cash out. Will be interesting to see how he does that.